Back to search results

Proximal Femur Replacement Study: Abductor Reattachment Methods

This observational study is looking at different ways to reattach abductor muscles during a Proximal Femur Replacement (a surgery where part of your thigh bone near the hip is replaced with an artificial one, often due to sarcoma or bone metastases). Researchers want to see if reattaching these muscles directly to the artificial bone leads to better hip function. They will measure this using scores like the Musculoskeletal Tumor Society (MSTS) score and the Harris Hip Score, and by tracking complications for up to 24 months after surgery. You may be able to join if you are between 16 and 75 years old, have had or are scheduled for this surgery, and are able to walk. The study is currently unclear on its recruitment status.

Study design
This is an observational study aiming to enroll 50 participants. It will look back at existing patient records and also include new patients.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 24 months after their surgery to assess outcomes and complications.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03261544

Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?

Recruiting
Not specifiedAges 16–75Observational
Duke University
~50 participants
Updated 2026-07-15 on ClinicalTrials.gov
What's tested:Proximal Femur Replacement

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The Musculoskeletal Tumor Society (MSTS) score
Measured over up to 24 months postoperatively
+2 more outcomes measured

Conditions

Sarcoma
Bone Metastases
Proximal Femur Replacement

Explore related trials

Metastatic Malignant Neoplasm in the BoneProximal Femur ReplacementSarcoma

NCT03261544

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Duke University

    Durham, North Carolinano site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • William Eward, MD, DVM · PRINCIPAL_INVESTIGATOR · Duke University

Who to contact

Elizabeth Sachs, MS
[email protected]
9196609849
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Non-ambulatory before or after the procedure
Subjects who, in the opinion of the investigator, have not or likely will not complete at least some portion of the investigator's recommended follow-up

What this trial measures

  • The Musculoskeletal Tumor Society (MSTS) scoreup to 24 months postoperatively

    The Musculoskeletal Tumor Society (MSTS) score of extremity function. The total score ranges from 0 to 30, with higher scores indicating better function.

  • Harris Hip Scoreup to 24 months postoperatively

    The Harris Hip Score (HHS) is a clinician-based outcome measure that is frequently used for the evaluation of patients following a Total Hip Arthroplasty (THA). The survey has ten questions and scores ranging from 0-100, with higher scores representing less dysfunction and better outcomes.

  • Number of patients with an implant-related complication as reported on the adverse event form upon participation completion.up to 24 months postoperatively

    The adverse event form records the occurence of implant-related complications that occur during study participation.